D-0422-2019 Class II Terminated
FDA drug recall D-0422-2019 was initiated by Sun Pharmaceutical Industries, Inc. on Jan 24, 2019 and is designated Class II. Reason for recall: Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance. The recall status is terminated (terminated Feb 22, 2021). Affected quantity: 69840 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 6, 2019
- Initiation Date
- Jan 24, 2019
- Termination Date
- Feb 22, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 69840 bottles
Product description
BromSite (bromfenac ophthalmic solution) 0.075%, 5 mL bottles, Rx Only, Distributed by : Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, NDC 49708-754-41
Reason for recall
Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.
Distribution pattern
Nationwide within the United States
Code information
Lot #: V18E01, Exp. 05/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0422-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026